跳转至内容
Merck
CN
所有图片(1)

主要文件

安全信息

H-003

Supelco

氢可酮标准液 溶液

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C18H21NO3
CAS号:
125-29-1
分子量:
299.36
UNSPSC代码:
41116107
NACRES:
NA.24

等级

certified reference material

质量水平

300

表单

liquid

特点

Snap-N-Spike®/Snap-N-Shoot®

包装

ampule of 1 mL

制造商/商品名称

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)

浓度

1.0 mg/mL in methanol

技术

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

应用

forensics and toxicology

包装形式

single component solution

储存温度

−20°C

SMILES字符串

N1([C@H]2[C@H]3[C@@]4([C@@H](Oc5c4c(ccc5OC)C2)C(=O)CC3)CC1)C.O[C@H]([C@@H](O)C(=O)O)C(=O)O.O

InChI

1S/C18H21NO3.C4H6O6.H2O/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19;5-1(3(7)8)2(6)4(9)10;/h3,6,11-12,17H,4-5,7-9H2,1-2H3;1-2,5-6H,(H,7,8)(H,9,10);1H2/t11-,12+,17-,18-;1-,2-;/m01./s1

InChI key

ZICRJLQTAUVSDU-NSJZFRMTSA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

一般描述

氢可酮是一种半合成的阿片类药物，来源于两种天然存在的阿片类药物可待因或蒂巴因。该药物也称为二氢可待因酮，可用作治疗疼痛的镇痛药和咳嗽或相关疾病的止咳药。该认证加标溶液®适合用作校准品或对照品的起始原料，用于药物研究、止痛药处方监测、临床毒理学和法医分析中的各种GC/MS或LC/MS检测应用。

应用


  • 酒石酸氢可酮缓释剂：慢性疼痛综述。: 这篇综述评估了氢可酮的缓释制剂，重点关注其药理学特性、疗效和在慢性疼痛管理方面的临床应用，强调了其在长期疼痛管理策略中的重要性（Dhillon S, 2016）。

推荐产品

在我们的NMR在线平台ChemisTwin®上可以找到本品对应的数字化标准物质。您可使用ChemisTwin®上的数字等效品鉴定您的样品并进行定量分析（使用数字化外标）。可查看该物质的NMR谱图，只需点击几次鼠标，就能进行在线样品比对。欢迎点击了解更多，开启免费试用之旅。

法律信息

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

相关产品

产品编号
说明
价格

H-005

氢可酮-d3 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

P-071

13种疼痛管理混标 溶液, 100 μg/mL each component (10 μg/mL Fentanyl), ampule of 1.0 mL, certified reference material, Cerilliant®

O-020

五种阿片类混标 溶液, 250 μg/mL each component in methanol, ampule of 1.0 mL, certified reference material, Cerilliant®

H-008

氢可酮-d3 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-047

Hydrocodone-D6 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-048

Hydrocodone-D6 solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

N-053

盐酸去甲二氢可待因酮标准液 盐酸盐 溶液, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

N-054

去甲氢可酮-D3 盐酸盐 溶液, 100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

H-003S

氢可酮标准液 溶液, 1 mg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

警示用语：

Danger

危险分类

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

靶器官

Eyes

储存分类代码

3 - Flammable liquids

WGK

WGK 2

闪点(°F)

49.5 °F - closed cup

闪点(°C)

9.7 °C - closed cup

法规信息

监管及禁止进口产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Elizabeth A Micks et al.
Obstetrics and gynecology, 120(5), 1060-1069 (2012-10-24)
Although hydrocodone-acetaminophen is commonly used for pain control in first-trimester abortion, the efficacy of oral opioids for decreasing pain has not been established. Our objective was to estimate the effect of hydrocodone-acetaminophen on patient pain perception during first-trimester surgical abortion.
How well can urine hydrocodone measurements discriminate between different hydrocodone prescription dosage rates?
Laura J McCloskey et al.
Clinica chimica acta; international journal of clinical chemistry, 419, 119-121 (2013-02-23)
Kathryn P Anastassopoulos et al.
Journal of opioid management, 9(2), 97-109 (2013-05-28)
Pain is a prevalent condition that often involves a neuropathic component. Hydrocodone is one of the most widely used opioids for pain but is often associated with side effects (SEs). This study sought to characterize the experience of patients taking
FDA panel recommends tighter rules for prescribing opioids.
Michael McCarthy
BMJ (Clinical research ed.), 346, f1012-f1012 (2013-02-16)
Amadeo Pesce et al.
Pain physician, 15(5), E687-E692 (2012-09-22)
A number of studies indicate that 10.8%-34% of patients with chronic pain use illicit drugs. One hypothesis for this occurrence is that some patients may be supplementing their prescription medications with illicit drugs. The primary purpose of this retrospective data
查看所有相关文献

商品

Benefits of Ascentis Express Phenyl-Hexyl over Biphenyl for the Separation of Pain Management Opiates

Although both biphenyl and phenyl-hexyl phases can resolve these compounds, the former exhibits excellent peak shape and substantially less silanol-derived ion exchange activity.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门